Evaluation of Short-to-medium Term Efficacy of Guselkumab and Secukinumab in Overweight and Obese Patients with Moderate to Severe Plaque Psoriasis: A 24-Week Single-center Retrospective Study
Background: Overweight and obesity are common in patients with psoriasis and are associated with increased disease severity and declined treatment response. Aims: To evaluate the short-to-medium term (24w) efficacy and safety of two biologics, including Guselkumab and Secukinumab, in overweight and...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Wolters Kluwer Medknow Publications
2025-09-01
|
| سلاسل: | Indian Journal of Dermatology |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://journals.lww.com/10.4103/ijd.ijd_663_23 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|